ProHealth health Vitamin and Natural Supplement Store and Health
Home  |  Log In  |  My Account  |  View Cart  View Your ProHealth Vitamin and Supplement Shopping Cart
800-366-6056  |  Contact Us  |  Help
Facebook Google Plus
Fibromyalgia  Chronic Fatigue Syndrome & M.E.  Lyme Disease  Natural Wellness  Supplement News  Forums  Our Story
Store     Brands   |   A-Z Index   |   Best Sellers   |   New Products   |   Deals & Specials   |   Under $10   |   SmartSavings Club

Trending News

Vitamin D supplements, sleep could help manage pain

Bacopa: The Herb That May Increase Your Brain Power

Eat More Yogurt and Avoid Osteoporosis

Lilac Oil: More Than Just for Fragrance

What Is Bilberry Good For?

Coffee, herbal tea may help prevent liver fibrosis

Crafty Uses for Carrot Seed Oil

Higher omega 3 levels linked to improved brain blood flow

Curcumin, resveratrol, ursolic acid show promise against prostate cancer

Olive oil compound could help protect against brain cancer

 
Print Page
Email Article

Benefits of Treating Behavioral, Functional Problems Caused by Alzheimer’s Disease

  [ 77 votes ]   [ Discuss This Article ]
www.ProHealth.com • January 10, 2003


A class of drugs known as cholinesterase inhibitors has a significant impact on behavioral problems and the ability to perform everyday tasks in patients with Alzheimer’s disease, according to a study led by researchers at the San Francisco VA Medical Center (SFVAMC) and UCSF.

The study, an analysis of data from multiple small studies, appears in the January 8, 2003 issue of the Journal of the American Medical Association. Known as a meta-analysis, the study applied sophisticated statistical methods to data from 29 trials that involved the treatment of Alzheimer’s disease (AD) with cholinesterase inhibitors (ChIs).

People with AD can suffer cognitive, behavioral or functional difficulties. ChIs have been previously shown to effectively treat cognitive difficulties such as memory loss, disorientation and loss of language skills, said Kristine Yaffe, MD, Chief of Geriatric Psychiatry at the SFVAMC and UCSF assistant professor of psychiatry, neurology and epidemiology and biostatistics.

“Until now, the jury has been out on whether these drugs really worked for behavioral and functional symptoms,” said Yaffe, senior author of the JAMA article.

The current analysis revealed that patients treated with ChIs scored slightly higher on standard tests used to assess behavioral and functional status in patients with mild to moderate AD. These kinds of small, statistically significant increases in scores often translate into large impacts on behavior-related health problems, Yaffe said.

Approximately 4 million Americans have Alzheimer’s disease, a progressive disorder that leads to varying degrees of dementia and for which there is currently no cure. The deterioration of the brain characteristic of Alzheimer’s disease most often results in cognitive difficulties, such as memory loss.

About half the people suffering from the disease experience behavioral problems that can include changes in their personality, agitation, anxiety, delusions or hallucinations. Functional difficulties—such as the ability to balance a checkbook, shop for groceries or perform simple domestic tasks—are key features of Alzheimer’s disease and other dementias. The noted improvement may or may not be the result of improved cognitive function, Yaffe said.

According to Yaffe, participants in the studies done to date didn’t necessarily exhibit symptoms in all three categories of problems associated with AD. She said clinical trials that specifically enroll people with behavioral problems are needed to further resolve the issues associated with the use of the drugs.

Long-term research is also needed to determine the effects of these drugs on both patients and their caregivers during the progression of the disease. “We need to know how the small effects of the drugs translate into long-term benefits, such as improvements in quality of life for patients and decreases in burdens to caregivers,” Yaffe said.



Post a Comment

Featured Products From the ProHealth Store
FibroSleep™ Mitochondria Ignite™ with NT Factor® Energy NADH™ 12.5mg

Looking for Vitamins, Herbs and Supplements?
Search the ProHealth Store for Hundreds of Natural Health Products


Article Comments



Be the first to comment on this article!

Post a Comment


 
NAD+ Ignite with Niagen

Featured Products

Energy NADH™ 12.5mg Energy NADH™ 12.5mg
Improve Energy & Cognitive Function
Vitamin D3 Extreme™ Vitamin D3 Extreme™
50,000 IU Vitamin D3 - Prescription Strength
Ultra EPA  - Fish Oil Ultra EPA - Fish Oil
Ultra concentrated source of essential fish oils
Mitochondria Ignite™ with NT Factor® Mitochondria Ignite™ with NT Factor®
Reduce Fatigue up to 45%
Ultra ATP+, Double Strength Ultra ATP+, Double Strength
Get energized with malic acid & magnesium

Natural Remedies

Breakthrough Form of Magnesium Enhances Memory and Cognitive Function Breakthrough Form of Magnesium Enhances Memory and Cognitive Function
Could a B-12 Deficiency Be Causing Your Symptoms? Could a B-12 Deficiency Be Causing Your Symptoms?
Fighting Fatigue with Ground-breaking French Oak Wood Extract Fighting Fatigue with Ground-breaking French Oak Wood Extract
Break Free From Fibromyalgia Break Free From Fibromyalgia
Natural Support for Mood, Sleep and Mental Focus? L-theanine Natural Support for Mood, Sleep and Mental Focus? L-theanine

CONTACT US
ProHealth, Inc.
555 Maple Ave
Carpinteria, CA 93013
(800) 366-6056  |  Email

· Become a Wholesaler
· Vendor Inquiries
· Affiliate Program
SHOP WITH CONFIDENCE
Credit Card Processing
SUBSCRIBE TO OUR NEWSLETTERS
Get the latest news about Fibromyalgia, M.E/Chronic Fatigue Syndrome, Lyme Disease and Natural Wellness

CONNECT WITH US ProHealth on Facebook  ProHealth on Twitter  ProHealth on Pinterest  ProHealth on Google Plus

© 2017 ProHealth, Inc. All rights reserved. Pain Tracker App  |  Store  |  Customer Service  |  Guarantee  |  Privacy  |  Contact Us  |  Library  |  RSS  |  Site Map